The Biden administration says 10 pharmaceuticals can be topic to cost negotiations with Medicare. The White Home says some costs may very well be lower in half. Bloomberg’s John Tozzi studies.
Comply with Bloomberg for enterprise information & evaluation, up-to-the-minute market information, options, profiles and extra: http://www.bloomberg.com
Join with us on…
Twitter: https://twitter.com/enterprise
Fb: https://www.fb.com/bloombergbusiness/
Instagram: https://www.instagram.com/quicktake/?hl=en
